Navigation Links
Are One-Third of Costly Implanted Heart Devices Unnecessary?

This year, Medicare will pay for tens of thousands of heart patients to have high-tech devices implanted in their chests. Called ICDs or //implantable cardioverter defibrillators, the expensive devices are designed to shock damaged hearts back into rhythm and save patients from sudden cardiac death, which kills 300,000 Americans each year.

But a new study finds that while many of these patients will benefit from their ICDs, a large number won’t — and a simple heart-rhythm test can tell who’s who.

In fact, the study suggests that if the test were used on the majority of ICD candidates, as many as one-third could be spared the operation to implant a device, without raising their risk of sudden death. That would mean that Medicare could be spared the additional $90,000 lifetime cost of each device compared to best medical therapy.

The study, published in the January issue of the Journal of the American College of Cardiology, is based on data from 768 patients who were candidates for ICDs at Christ Hospital and the Ohio Heart and Vascular Center in Cincinnati. All of the patients had survived heart attacks but had permanent damage to their heart muscle caused by lack of blood flow — a condition called ischemic cardiomyopathy.

Each patient received a test called microvolt T-wave alternans or MTWA, along with a battery of other tests, during their evaluation. Half of the patients went on to receive ICDs, although the MTWA test results weren’t used in the decision-making process. The patients’ health and the causes of any deaths were tracked for up to three years.

After that time, the data were analyzed by researchers from the University of Michigan Cardiovascular Center and VA Ann Arbor Healthcare System, in cooperation with the Ohio team.

In all, 67 percent of patients had positive or inconclusive MTWA test results. Of them, the patients who went on to receive an ICD were 55 percent less likely to die in
'"/>




Page: 1 2 3

Related medicine news :

1. One-Third of Scottish Pregnancies, a Mishap
2. One-Third of Sexually Active Older Adults With HIV/AIDs Has Unprotected Sex
3. Child-Care In Canada A Costly Affair
4. Costly mistakes help better understand OCD: obsessive compulsive disorder
5. Study Explains How Costly Traits Evolve
6. The Evolution of Costly Traits
7. Learning Disabilities If Undetected Early Proves Costly Later
8. Omega -3 Fatty Acids Better than Implanted Defibrillators
9. Epilepsy Treated with Implanted Devices
10. Nerve Conduction Studies Safe for Patients with Implanted Cardiac Devices
11. Digital ID Chips Implanted in Dogs to Prevent Rabies
Post Your Comments:
Breaking Medicine Technology:Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 2Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 3Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 4Genomic Health Announces Publication of Study of Oncotype DX(R) in Node-Positive Breast Cancer That Identifies Patients Who Do Not Appear to Benefit From Chemotherapy 5RetireSafe Announces Intention to Key Vote Senator Dorgan's Drug Importation Amendment (SA 2793) 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 2AdEx Media, Inc. Signs Agreement with Medical Alarm Concepts 3USC researchers identify regulatory genetic sequences that may predict risk for prostate cancer 9582 1NuAire Laboratory Economic Stimulus Package Free Accessories or Factory Options 13569 1Wine May Shield Breast Cancer Patients From Radiation Side Effects 54558 1Wine May Shield Breast Cancer Patients From Radiation Side Effects 54558 2